These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 37665342)
1. Intervertebral disc degeneration and inflammatory microenvironment: expression, pathology, and therapeutic strategies. Chen X; Wang Z; Deng R; Yan H; Liu X; Kang R Inflamm Res; 2023 Sep; 72(9):1811-1828. PubMed ID: 37665342 [TBL] [Abstract][Full Text] [Related]
2. Regulatory Effect of Inflammatory Mediators in Intervertebral Disc Degeneration. Li Z; Yang H; Hai Y; Cheng Y Mediators Inflamm; 2023; 2023():6210885. PubMed ID: 37101594 [TBL] [Abstract][Full Text] [Related]
3. The role of IL-1β and TNF-α in intervertebral disc degeneration. Wang Y; Che M; Xin J; Zheng Z; Li J; Zhang S Biomed Pharmacother; 2020 Nov; 131():110660. PubMed ID: 32853910 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration. Wang C; Yu X; Yan Y; Yang W; Zhang S; Xiang Y; Zhang J; Wang W Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):1-13. PubMed ID: 27864283 [TBL] [Abstract][Full Text] [Related]
5. Gut-disc axis: A cause of intervertebral disc degeneration and low back pain? Li W; Lai K; Chopra N; Zheng Z; Das A; Diwan AD Eur Spine J; 2022 Apr; 31(4):917-925. PubMed ID: 35286474 [TBL] [Abstract][Full Text] [Related]
6. The mechanisms and functions of TNF-α in intervertebral disc degeneration. Pan H; Li H; Guo S; Wang C; Long L; Wang X; Shi H; Zhang K; Chen H; Li S Exp Gerontol; 2023 Apr; 174():112119. PubMed ID: 36758650 [TBL] [Abstract][Full Text] [Related]
7. Fucoidan-loaded nanofibrous scaffolds promote annulus fibrosus repair by ameliorating the inflammatory and oxidative microenvironments in degenerative intervertebral discs. Yu Q; Han F; Yuan Z; Zhu Z; Liu C; Tu Z; Guo Q; Zhao R; Zhang W; Wang H; Mao H; Li B; Zhu C Acta Biomater; 2022 Aug; 148():73-89. PubMed ID: 35671874 [TBL] [Abstract][Full Text] [Related]
8. Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis. Gong Y; Qiu J; Jiang T; Li Z; Zhang W; Zheng X; He Z; Chen W; Wang Z; Feng X; Wang M; Hong Z Inflammopharmacology; 2023 Feb; 31(1):369-384. PubMed ID: 36401729 [TBL] [Abstract][Full Text] [Related]
9. Growth and differentiation factor-5 contributes to the structural and functional maintenance of the intervertebral disc. Feng C; Liu H; Yang Y; Huang B; Zhou Y Cell Physiol Biochem; 2015; 35(1):1-16. PubMed ID: 25547527 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of Pluripotent Stem Cells into Nucleus Pulposus Progenitor Cells for Intervertebral Disc Regeneration. Xia K; Gong Z; Zhu J; Yu W; Wang Y; Wang J; Xu A; Zhou X; Tao H; Li F; Liang C Curr Stem Cell Res Ther; 2019; 14(1):57-64. PubMed ID: 30227822 [TBL] [Abstract][Full Text] [Related]
11. M2 macrophage-conditioned medium inhibits intervertebral disc degeneration in a tumor necrosis factor-α-rich environment. Li XC; Luo SJ; Fan W; Zhou TL; Huang CM; Wang MS J Orthop Res; 2022 Nov; 40(11):2488-2501. PubMed ID: 35170802 [TBL] [Abstract][Full Text] [Related]
12. Preclinical Li Z; Gehlen Y; Heizmann F; Grad S; Alini M; Richards RG; Kubosch D; Südkamp N; Izadpanah K; Kubosch EJ; Lang G Front Bioeng Biotechnol; 2020; 8():583. PubMed ID: 32587853 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-140-3p alleviates intervertebral disc degeneration Wang Z; Zhang S; Zhao Y; Qu Z; Zhuang X; Song Q; Leng J; Liu Y RNA Biol; 2021 Dec; 18(12):2247-2260. PubMed ID: 33904383 [TBL] [Abstract][Full Text] [Related]
14. HIF1A Alleviates compression-induced apoptosis of nucleus pulposus derived stem cells via upregulating autophagy. He R; Wang Z; Cui M; Liu S; Wu W; Chen M; Wu Y; Qu Y; Lin H; Chen S; Wang B; Shao Z Autophagy; 2021 Nov; 17(11):3338-3360. PubMed ID: 33455530 [TBL] [Abstract][Full Text] [Related]
15. Blocking the function of inflammatory cytokines and mediators by using IL-10 and TGF-β: a potential biological immunotherapy for intervertebral disc degeneration in a beagle model. Li W; Liu T; Wu L; Chen C; Jia Z; Bai X; Ruan D Int J Mol Sci; 2014 Sep; 15(10):17270-83. PubMed ID: 25264742 [TBL] [Abstract][Full Text] [Related]
16. Emerging role and therapeutic implications of p53 in intervertebral disc degeneration. Wang Y; Hu S; Zhang W; Zhang B; Yang Z Cell Death Discov; 2023 Dec; 9(1):433. PubMed ID: 38040675 [TBL] [Abstract][Full Text] [Related]
17. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration. Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004 [TBL] [Abstract][Full Text] [Related]
18. Correlational analysis of chemokine and inflammatory cytokine expression in the intervertebral disc and blood in patients with lumbar disc disease. Hiyama A; Suyama K; Sakai D; Tanaka M; Watanabe M J Orthop Res; 2022 May; 40(5):1213-1222. PubMed ID: 34191345 [TBL] [Abstract][Full Text] [Related]
19. Identification of key potential targets for TNF-α/TNFR1-related intervertebral disc degeneration by bioinformatics analysis. Hong J; Yan J; Chen J; Li S; Huang Y; Huang Z; Chen W; Liang A; Ye W Connect Tissue Res; 2021 Sep; 62(5):531-541. PubMed ID: 32686499 [TBL] [Abstract][Full Text] [Related]
20. The Mechanism and Function of miRNA in Intervertebral Disc Degeneration. Wang C; Cui L; Gu Q; Guo S; Zhu B; Liu X; Li Y; Liu X; Wang D; Li S Orthop Surg; 2022 Mar; 14(3):463-471. PubMed ID: 35142050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]